Therefore, in order to critically evaluate strategy of resuming TNF inhibitors after tuberculosis treatment, we sought to assess the safety of resuming TNF inhibitors concomitantly with or after completing anti-tuberculosis chemotherapy based on a present nationwide study in an intermediate tuberculosis burden area. Here, TNF is linked to tuberculosis.